Orbas-20 Tablet

Orbas-20 Tablet সম্পর্কে

Orbas-20 হলো Olmesartan Medoxomil-এর একটি ব্র্যান্ড, শক্তি ২০ mg, ট্যাবলেট আকারে। Orbas-20 প্রস্তুত করেছে The ACME Laboratories Ltd। Olmesartan Medoxomil-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।

Olmesartan Medoxomil-এর ২৯টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Belsar 10 mg Tablet-এর, প্রতি ইউনিট ৳ ৬.০০।

Orbas-20 Tablet কী?

Orbas-20 20 mg tablet is a medicine made by The ACME Laboratories Ltd. Orbas-20 20 mg is a prescription tablet with the active ingredient Olmesartan Medoxomil, belonging to a class of medicines called angiotensin-II receptor blockers. By blocking this effect, the medicine helps blood vessels relax and lowers blood pressure. Follow the instructions given to you and do not change the dose yourself.

Orbas-20-এর ব্যবহার

Orbas-20 is used to treat hypertension, which means high blood pressure. Orbas-20 is used for the treatment of hypertension, commonly known as high blood pressure. Only a qualified doctor can decide if this medicine is suitable for a particular person and how it should be used. Ask your doctor whether it is right for your condition.

Orbas-20 কীভাবে ব্যবহার করবেন

Keep all follow-up appointments so your blood pressure can be monitored. Swallow the tablet with water. Orbas-20 is taken by mouth. Take Orbas-20 exactly as prescribed by your doctor. Do not change the dose or stop taking it without talking to your doctor first. The dose and how often you take it are decided by your doctor, who may adjust them over time.

Orbas-20-এর পার্শ্বপ্রতিক্রিয়া

Like all medicines, Orbas-20 can cause side effects, but not everyone gets them. The most common side effects include back pain, bronchitis, increased creatine phosphokinase, diarrhoea, headache, blood in urine, high blood sugar, high triglycerides, influenza-like symptoms, sore throat, runny nose, and sinusitis. Tell your doctor if any side effect bothers you or does not go away. Tell your doctor or pharmacist if you feel unwell or notice anything unusual, and seek medical help for severe symptoms.

সতর্কতা ও নিরাপত্তা

People with kidney problems or severe heart failure should speak to their doctor first, as kidney function may change. It is not known if it passes into breast milk, so discuss with your doctor if you are nursing. If you are pregnant or planning pregnancy, speak to your doctor, as medicines acting on the renin-angiotensin system can harm the developing baby and should be stopped when pregnancy is detected. Tell your doctor about kidney problems, liver problems, heart failure or other medical conditions before starting it, because kidney function may change in some people taking this type of medicine.

সাধারণ প্রশ্ন

Why is Orbas-20 prescribed?

Orbas-20 is used to treat hypertension, which means high blood pressure. Orbas-20 is used for the treatment of hypertension, commonly known as high blood pressure.

How should I take Orbas-20?

Keep all follow-up appointments so your blood pressure can be monitored. Swallow the tablet with water.

Can Orbas-20 cause side effects?

Like all medicines, Orbas-20 can cause side effects, but not everyone gets them. The most common side effects include back pain, bronchitis, increased creatine phosphokinase, diarrhoea, headache, blood in urine, high blood sugar, high triglycerides, influenza-like symptoms, sore throat, runny nose, and sinusitis.

Can I use Orbas-20 in pregnancy or while breastfeeding?

People with kidney problems or severe heart failure should speak to their doctor first, as kidney function may change. It is not known if it passes into breast milk, so discuss with your doctor if you are nursing.

নির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Olmesartan Medoxomil is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.

ফার্মাকোলজি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Angiotensin-II formed from angiotensin-I in a reaction catalyzed by angiotensin-converting enzyme (ACE), is a potent vasoconstrictor, the primary vasoactive hormone of the renin-angiotensin system and an important component in the pathophysiology of hypertension. It also stimulates aldosterone secretion by the adrenal cortex. Olmesartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin-II by selectively blocking the binding of angiotensin-II to the AT 1 receptor found in many tissues (e.g. vascular smooth muscle, adrenal gland). In-vitro-binding studies indicate that Olmesartan is a reversible & competitive inhibitor of AT 1 receptor. Olmesartan does not inhibit ACE (kinase-I, the enzyme that converts angiotensin-I to angiotensin-II and degrades bradykinin).

মাত্রা ও সেবনবিধি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Dosage must be individualized. The usual recommended starting dose of Olmesartan is 20 mg once daily when used as monotherapy in patients who are not volume-contracted. For patients requiring further reduction in blood pressure after 2 weeks of therapy, the dose of Olmesartan may be increased to 40 mg. Doses above 40 mg do not appear to have a greater effect. Twice-daily dosing offers no advantage over the same total dose given once daily.

No initial dosage adjustment is recommended for elderly patients, for patients with moderate to marked renal impairment (creatinine clearance <40 ml/min) or with moderate to marked hepatic dysfunction. For patients with possible depletion of intravascular volume (e.g. patients treated with diuretics, particularly those with impaired renal function), Olmesartan should be initiated under close medical supervision and consideration should be given to use of a lower starting dose. Olmesartan may be administered with or without food.

ঔষধের মিথষ্ক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

With medicine: No significant drug interactions were reported in which Olmesartan was co-administered.
With food & others: Food does not affect the bioavailability of Olmesartan.

প্রতিনির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Olmesartan is contraindicated in patients who are hypersensitive to any component of this product.

পার্শ্ব প্রতিক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Common: The most common side effects include Back pain, bronchitis, creatine phosphokinase increased, diarrhea, headache, hematuria, hyperglycemia, hypertriglyceridemia, influenza-like symptoms, pharyngitis, rhinitis, and sinusitis.

Rare: Chest pain, peripheral edema, arthritis.

গর্ভাবস্থায় ও স্তন্যদানকালে

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Pregnancy: When pregnancy is detected, discontinue this product as soon as possible. When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus.

Nursing Mothers: It is not known whether Olmesartan is excreted in human milk, but Olmesartan is secreted at low concentration in the milk of lactating rats. Because of the potential for adverse effects on the nursing infant, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

সতর্কতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals treated with olmesartan medoxomil. In patients whose renal function may depend upon the activity of the renin-angiotensin-aldosterone system (e.g. patients with severe congestive heart failure), treatment with angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists has been associated with oliguria and/or progressive azotemia and (rarely) with acute renal failure and/or death. Similar results may be anticipated in patients treated with olmesartan medoxomil.

মাত্রাধিক্যতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Symptoms: There is no experience of overdose with Olmesartan. The most likely effects of olmesartan medoxomil overdosage are hypotension and tachycardia; bradycardia could be encountered if parasympathetic (vagal) stimulation occurred.

Treatment: If intake is recent, gastric lavage or induction of emesis may be considered. Clinically significant hypotension due to an overdose of Olmesartan requires the active support of the cardiovascular system, including close monitoring of heart and lung function, the elevation of the extremities, and attention to circulating fluid volume and urine output.

সংরক্ষণ

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Store in cool & dry place below 30ºC, protect from light & moisture. Keep out of the reach of children.

বিকল্প ব্র্যান্ড: Olmesartan Medoxomil

একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।

সব দেখুন ২৯ ব্র্যান্ড

ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।